| Literature DB >> 19055789 |
Linda Casebeer1, Sally Engler, Nancy Bennett, Martin Irvine, Destry Sulkes, Marc DesLauriers, Sijian Zhang.
Abstract
BACKGROUND: The internet has had a strong impact on how physicians access information and on the development of continuing medical education activities. Evaluation of the effectiveness of these activities has lagged behind their development.Entities:
Mesh:
Year: 2008 PMID: 19055789 PMCID: PMC2612689 DOI: 10.1186/1741-7015-6-37
Source DB: PubMed Journal: BMC Med ISSN: 1741-7015 Impact factor: 8.775
Demographics of physician internet CME participants and non-participants
| Age, years | ||
| Average | 53.0 | 51.3 |
| SD | 10.0 | 8.1 |
| Years since graduation | ||
| Average | 26.1 | 24.6 |
| SD | 10.3 | 8.4 |
| Gender, number (%) | ||
| Female | 736 (27) | 537 (21) |
| Male | 2003 (73) | 1964 (79) |
| Degree, number (%) | ||
| DO | 116 (4) | 130 (5) |
| MD | 2668 (96) | 2688 (95) |
| Direct patient care as principal responsibility, number (%) | 2572 (94) | 2621 (94) |
Interactive CME cases
| The diagnosis and treatment of schizophrenia | 33 | 66 | 15 | 46 | 53 | 20 | 0.75 |
| Generalized Anxiety Disorder | 32 | 66 | 21 | 26 | 56 | 15 | 0.56 |
| Attention Deficit Hyperactivity Disorder case studies | 32 | 91 | 13 | 33 | 82 | 18 | 0.60 |
| The evolving face of Attention Deficit Hyperactivity Disorder | 49 | 78 | 23 | 45 | 54 | 25 | 0.59 |
| Diagnosis/Management of Attention Deficit Hyperactivity Disorder | 36 | 78 | 19 | 36 | 60 | 18 | 0.98 |
| Advances in Restless Leg Syndrome | 64 | 89 | 16 | 58 | 55 | 24 | 1.68 |
| Advances in stroke | 77 | 91 | 11 | 58 | 63 | 19 | 1.89 |
| Emerging concepts in the treatment of multiple sclerosis | 21 | 62 | 19 | 25 | 46 | 17 | 0.89 |
| Pulmonary arterial hypertension | 32 | 84 | 14 | 31 | 58 | 18 | 1.61 |
| Predicting heart failure | 26 | 71 | 24 | 28 | 49 | 19 | 1.02 |
| Hypertension highlights | 101 | 73 | 27 | 92 | 49 | 25 | 0.91 |
| Managing the rheumatoid arthritis patient | 48 | 81 | 18 | 49 | 68 | 25 | 0.60 |
| Early and aggressive treatment of rheumatoid arthritis | 38 | 71 | 22 | 39 | 43 | 27 | 1.15 |
| Assessment of the patient with rheumatoid arthritis | 17 | 74 | 23 | 17 | 47 | 16 | 1.37 |
| Safety of biologic agents in the treatment of rheumatoid arthritis | 22 | 86 | 15 | 18 | 59 | 23 | 1.38 |
| Urinary frequency in an elderly woman | 60 | 93 | 13 | 52 | 78 | 19 | 0.95 |
| Improving outcomes in benign prostatic hyperplasia | 68 | 78 | 20 | 50 | 62 | 15 | 0.90 |
| Obesity, erectile dysfunction and hypertension | 60 | 85 | 18 | 60 | 48 | 30 | 1.49 |
| Treating overactive bladder in the elderly patient | 103 | 76 | 22 | 95 | 55 | 27 | 0.84 |
| Antimicrobial resistance | 49 | 70 | 23 | 49 | 42 | 19 | 1.34 |
| Emergent presentation and treatment of influenza in children | 69 | 76 | 20 | 65 | 61 | 22 | 0.72 |
| Diagnosis/treatment of asthma in infants and young children | 60 | 90 | 13 | 61 | 60 | 20 | 1.70 |
| Diagnosis of Chronic Obstructive Pulmonary Disorder and asthma | 17 | 92 | 16 | 17 | 74 | 15 | 1.13 |
| Contraception in a woman with a history of fibroids | 53 | 79 | 22 | 47 | 68 | 21 | 0.52 |
Effect size of text-based clinical updates
| Identifying patients with prodromal schizophrenia | 35 | 73 | 12 | 28 | 49 | 16 | 1.76 |
| Treatment nonadherence among individuals with schizophrenia | 52 | 71 | 17 | 47 | 54 | 21 | 0.90 |
| Treatment resistant schizophrenia | 50 | 77 | 18 | 50 | 60 | 15 | 1.08 |
| Reducing suicide risk in patients with schizophrenia | 49 | 81 | 21 | 46 | 59 | 27 | 0.92 |
| Recognizing and preventing abuse of rapid-onset opioids | 50 | 68 | 21 | 57 | 48 | 21 | 0.93 |
| Detecting autism in a toddler | 100 | 68 | 19 | 102 | 50 | 22 | 0.85 |
| Hyperactivity or autism | 101 | 61 | 19 | 95 | 47 | 20 | 0.73 |
| Maximizing therapeutic success in an era of increasing antibiotic resistance | 43 | 73 | 27 | 43 | 51 | 28 | 0.80 |
| The role of antibiotics in serious hospital acquired infections | 47 | 87 | 20 | 54 | 71 | 19 | 0.82 |
| Fungal infection in the immunocompromised patient | 47 | 68 | 21 | 39 | 54 | 21 | 0.65 |
| Prostate cancer | 26 | 71 | 24 | 28 | 49 | 19 | 0.28 |
| Lower urinary tract symptoms in men | 24 | 74 | 23 | 24 | 58 | 20 | 0.77 |
| Evaluation and treatment of overactive bladder | 41 | 74 | 29 | 45 | 63 | 28 | 0.37 |
| Erectile dysfunction and cardiovascular disease | 29 | 63 | 14 | 25 | 57 | 22 | 0.32 |
| Statin efficacy and prevention of recurrent stroke | 22 | 83 | 11 | 22 | 60 | 16 | 1.62 |
| Diabetes, Metabolic Syndrome and very low cholesterol | 59 | 88 | 21 | 59 | 72 | 30 | 0.62 |
| Statins in the treatment of heart failure | 50 | 60 | 18 | 49 | 45 | 19 | 0.83 |
| Advances in hypertension | 22 | 82 | 18 | 22 | 58 | 27 | 1.04 |
| Medical adherence | 22 | 55 | 22 | 22 | 38 | 16 | 0.89 |
| Analysis of latest trial data points to new guidelines & restructured hypertension therapy | 50 | 85 | 19 | 49 | 59 | 25 | 1.04 |
| The role of MRI in multiple sclerosis diagnosis and management | 53 | 64 | 21 | 53 | 46 | 19 | 0.89 |
| Breakthrough pain | 73 | 75 | 27 | 73 | 48 | 29 | 0.98 |
| Risks and benefits of COX-2 selective inhibitors | 85 | 70 | 23 | 98 | 62 | 24 | 0.36 |
| Contraception today | 18 | 79 | 21 | 21 | 57 | 20 | 1.12 |
Effect size of 48 internet CME activities by format and specialty
| All 48 internet CME activities | 5621 | 0.75 | 45.2% |
| 24 text-based internet CME activities | 2780 | 0.63 | 39.8% |
| 24 case-based internet CME activities | 2841 | 0.89 | 51.0% |
| All activities/primary care participants | 2818 | 0.83 | 48.5% |
| All activities/specialist participants | 2511 | 0.70 | 43.0% |